LINE

Text:AAAPrint
Ecns wire

China Meheco signs contract to distribute Pfizer's COVID treatment drug in China

2022-12-15 10:27:55Ecns.cn Editor : Zhang Dongfang ECNS App Download
Photo shows an announcement released by China Meheco, Dec. 12, 2022. (Screenshot Photo)

Photo shows an announcement released by China Meheco, Dec. 12, 2022. (Screenshot Photo)

(ECNS) -- China Meheco said on Wednesday it signed an agreement with Pfizer Inc to import and distribute its oral COVID-19 treatment Paxlovid in the Chinese mainland.

The agreement is valid between Dec. 14 and Nov. 30, 2023, China Meheco said in its announcement.

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

LINE
Media partners: People's Daily | Xinhua | CGTN | China Daily
Back to top About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2022 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证（0106168)] [京ICP证040655号]
[京公网安备 11010202009201号] [京ICP备05004340号-1]